Product Brochure
Reduced NMN Can Boost NAD+ by 10X Safety Validated
![Reduced NMN Can Boost NAD+ by 10X Safety Validated](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_product_file/publications/food-beverage-nutrition/nutraingredients-usa.com/product-innovations/reduced-nmn-can-boost-nad-by-10x-safety-validated/17453273-1-eng-GB/Reduced-NMN-Can-Boost-NAD-by-10X-Safety-Validated.png)
NMNH refers to the reduced form of NMN. Preclinical studies show that NMNH demonstrates a remarkable 10X surge in NAD+ levels.
UthPeak™, EffePharm's pioneering NMNH product, received significant attention during Vitafoods Europe 2024. UthPeak™ has completed rigorous toxicology and efficacy tests, proving its safety and benefits for anti-aging, anti-fatigue, and cardiovascular health.
UthPeak™ is currently conducting a phase I clinical trial, with results expected by the end of 2024. UthPeak™ NMNH finished products are available to purchase on Amazon.
Download the file now to learn more.